Multiple reports say a shortage of the chemotherapy medicine ifosfamide injection in the United States is increasing demand for potential suppliers in India. According to the reports, the relevant regulator has contacted the Indian Drug Manufacturers’ Association (IDMA) to identify Indian companies that can supply ifosfamide injection on short notice. Ifosfamide injection is a generic chemotherapy drug used to treat several cancers, including testicular, bladder and lung cancers.
The outlets also note that investors are watching major Indian pharmaceutical firms for potential involvement in meeting the supply demand linked to the US shortage. The specific companies mentioned in the coverage include Zydus, Sun Pharma and Dr Reddy’s, reflecting market interest in which manufacturers may be able to respond to the regulator’s request. The reports describe the action as an effort to locate immediate supply capacity rather than a finalized procurement decision. Details such as contract terms, timelines and quantities are not specified in the provided summaries.
